Moxalactam Therapy of Bacterial Meningitis in Adults

The therapeutic efficacy and attainable cerebrospinal fluid (CSF) concentrations of moxalactam, administered by intravenous drip in a dose of 2 g every 4 to 8 h, were evaluated in seven adult patients with bacterial meningitis. Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa,...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Uwaydah, Marwan, Tannir, Nizar, Kantarjian, Hagop, Osseiran, Maher, Bal'a, Farid
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1983
Matèries:	Clinical Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6220673/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.2.289
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!